VENUS REMEDIES SECURES GMP CERTIFICATION FROM MOLDOVA MINISTRY OF HEALTH FOR ANTIBIOTIC-CARBAPENEM FACILITY
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026 Bengaluru, December 31, 2024:
